Long-term dietary interventions fail to mitigate functional connectivity loss and cognitive decline in the TgF344-AD rat model of Alzheimers Disease

van Rooij, J. R. A.; van den Berg, M.; Van Vosselen, M.; Calus, E.; Vasilkovska, T.; Kosten, L.; Van Spilbeeck, I.; Van Audekerke, J.; van Dam, D.; Bertoglio, D.; Adhikari, M. H.; Verhoye, M.

doi:10.1101/2025.08.25.672063

bioRxiv · 10.1101/2025.08.25.672063

Long-term dietary interventions fail to mitigate functional connectivity loss and cognitive decline in the TgF344-AD rat model of Alzheimers Disease

van Rooij, J. R. A.·van den Berg, M.·Van Vosselen, M.·Calus, E.·Vasilkovska, T.·Kosten, L.·Van Spilbeeck, I.·Van Audekerke, J.·van Dam, D.·Bertoglio, D.·Adhikari, M. H.·Verhoye, M.

View original source ↗Export metadata ↓

Abstract

IntroductionAlzheimers disease (AD) is a complex neurodegenerative disorder, characterized by altered brain functional connectivity and network activity, detectable using resting-state functional MRI (rsfMRI). Caloric restriction (CR) and its mimetic resveratrol (Rsv) have shown potential in reducing AD-related pathology and preserving brain function, though research on long-term efficacy is limited. Therefore, we aimed to assess the effects of short- term CR and Rsv administrations on resting-state (rs) functional connectivity (FC), after which we assessed the effects of long-term CR and Rsv interventions on rs-FC, spatial memory, amyloid burden, and neuroinflammation in TgF344-AD rats (Tg) and wild-type (WT) littermates. Materials and MethodsWe used rsfMRI to investigate rs-FC changes after CR (40%) or daily Rsv supplementation (10 mg/kg, oral) in male and female, WT and TgF344-AD (Tg) rats at the age of 4 months and 11 months, after, respectively, 1 month (short-term) and 8 months (long- term) of either Rsv supplementation, control (Ctrl) or CR diet. Additionally, spatial memory was assessed utilizing the Morris Water Maze (MWM), followed by histological validation of amyloid plaque load (X34), astrogliosis (GFAP) and microgliosis (IBA-1) at 11 months of age. ResultsBoth long-term CR or Rsv supplementation exert limited effects in the TgF344-AD model on the known AD-related pathological hallmarks. Short-term CR led to a reduction in rs-FC in female TgF344-AD rats compared to Rsv Tg supplemented rats for connections primarily within and between the hippocampal network, while between other connections, CR reduced rs-FC compared to Ctrl in females, irrespective of genotype. Rsv increased rs-FC compared to CR for only a few connections in females, again irrespective of genotype. Long- term CR decreased rs-FC in male Tg CR rats, compared to Tg Ctrl and WT CR rats, primarily for connections within the lateral cortical network (LCN). For other connections, CR reduced rs- FC when compared to Ctrl, irrespective of genotype. Overall, Rsv supplementation showed negligible effects on rs-FC. Moreover, long-term CR yielded modest cognitive improvements in male Tg rats, as evidenced by enhanced performance in the MWM but not in females. Histological validation after long-term dietary intervention revealed region-specific increase or decrease of amyloid burden after CR or Rsv supplementation, respectively. Additionally, CR reduced IBA-1 levels in males, irrespective of genotype, GFAP levels were unaffected by long- term dietary intervention. ConclusionAltogether, our findings indicate that long-term CR and Rsv exert distinct and limited effects on AD-related pathology in the TgF344-AD model, with CR demonstrating a modest but greater effect on functional and cognitive measures compared to Rsv. This study underscores the difficulty of altering key disease processes with these long-term dietary approaches, highlighting the need for more comprehensive long-term studies to elucidate the potential modulatory role of dietary interventions on AD pathophysiology.

Source connections

Published article ↗

Explore related subjects

neuroscience Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

van Rooij, J. R. A., van den Berg, M., Van Vosselen, M., Calus, E., Vasilkovska, T., Kosten, L., Van Spilbeeck, I., Van Audekerke, J., van Dam, D., Bertoglio, D., Adhikari, M. H., Verhoye, M.. 2025-08-29. Long-term dietary interventions fail to mitigate functional connectivity loss and cognitive decline in the TgF344-AD rat model of Alzheimers Disease. https://doi.org/10.1101/2025.08.25.672063

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗